仙琚制药：产品“雌二醇片”取得注册证

Core Viewpoint - Xianju Pharmaceutical has received approval from the National Medical Products Administration for the registration of its estradiol tablets, which is a significant milestone for the company [1] Company Summary - Xianju Pharmaceutical's revenue composition for the first half of 2025 shows that pharmaceuticals account for 99.34% of total revenue, while other businesses contribute only 0.66% [1] - As of the report date, Xianju Pharmaceutical has a market capitalization of 9.9 billion yuan [1]